Not medical advice. Kisspeptin is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.
Kisspeptin-10 is the ten-amino-acid business end of the KISS1 gene product — the single most potent natural trigger of the reproductive hormone axis, acting one step upstream of GnRH itself.
One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.
Kisspeptin-10 is the C-terminal decapeptide of the KISS1 gene product that activates KISS1R (GPR54) on hypothalamic GnRH neurons, the master upstream trigger of the reproductive (HPG) axis.
Peer-reviewed literature typically discusses Kisspeptin in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.
Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.
Compounds in this family are frequently studied in models of tissue injury, wound closure, and how cells reorganise after damage. Research looks at cell movement, blood-vessel support, and inflammatory balance -not at replacing medical care.
Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.
Storage requirements: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. · Learn best practices in our detailed storage guide.
Research dosing context: Literature typically discusses Reported only as published research context — not a recommendation · Study- and route-dependent (bolus or continuous infusion in published kisspeptin pharmacology) · Kisspeptin-10 has a short circulating half-life (on the order of minutes); kisspeptin-54 is longer-acting. Published research doses are highly model-, species-, and route-specific and are not reproduced here as a protocol. Research use only — not for human use.
Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.
Kisspeptin-10 is the active C-terminal decapeptide of the KISS1 gene product (metastin). It works by binding KISS1R (GPR54), a Gq/11-coupled receptor on hypothalamic GnRH neurons, triggering phospholipase-C signalling and a calcium rise that makes those neurons fire and release GnRH. That GnRH pulse then drives pituitary LH and FSH secretion, placing kisspeptin at the very top of the reproductive hormone cascade.
A GnRH agonist acts directly on the pituitary side of the cascade. Kisspeptin acts one step earlier, on the GnRH neurons in the hypothalamus that release GnRH in the first place. That upstream position is why researchers use it to study the natural, physiological control of the reproductive axis rather than overriding it.
Controlled human physiology studies report that exogenous kisspeptin raises circulating LH (mean increase ~2.75 IU/L in one trial) and, more modestly, FSH, without altering downstream estradiol, progesterone or testosterone over short study windows. Randomised clinical trials in men and women with hypoactive sexual desire disorder also found that kisspeptin modulated activity in sexual-processing brain networks. These are published research findings, not human-use claims — kisspeptin is supplied for laboratory research only.
Kisspeptin-54 (metastin) is the full-length peptide; kisspeptin-10 is its C-terminal ten-amino-acid fragment. Both bind the same KISS1R receptor through the shared C-terminal sequence. Kisspeptin-10 is shorter and shorter-acting (a circulating half-life on the order of minutes), while kisspeptin-54 circulates longer, which is why studies pick one or the other depending on whether they need a brief pulse or sustained exposure.
The KISS1 gene was originally discovered as a metastasis-suppressor gene, and its product was named metastin before the reproductive role of its receptor (GPR54/KISS1R) was understood. Kisspeptin and metastin refer to the same molecule.
They act at opposite ends of the same axis. Kisspeptin acts at the top, on hypothalamic GnRH neurons, recruiting the body's own LH/FSH release in a physiological way. hCG acts at the bottom, directly on the gonad via the LH/CG receptor, mimicking the LH surge. Researchers choose kisspeptin to study upstream, natural control and hCG to drive direct gonadal stimulation.
Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water, refrigerate at 1–6 °C and protect from light. As with most research peptides, avoid repeated freeze-thaw cycles of the reconstituted solution. This is laboratory handling guidance only.
No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.
Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.
Primary literature and registries for Kisspeptin, plus mainstream coverage of the peptide category. Research use only - not medical advice.
Databases & literature:
Peptides in the news:
Access concentration, batch info, variants, and current pricing on our shop.
Also known as: Kisspeptin-10, KP-10, Metastin (45-54), KISS1, GPR54/KISS1R Agonist, Metastin C-Terminal Decapeptide